JP2007519619A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519619A5
JP2007519619A5 JP2006542704A JP2006542704A JP2007519619A5 JP 2007519619 A5 JP2007519619 A5 JP 2007519619A5 JP 2006542704 A JP2006542704 A JP 2006542704A JP 2006542704 A JP2006542704 A JP 2006542704A JP 2007519619 A5 JP2007519619 A5 JP 2007519619A5
Authority
JP
Japan
Prior art keywords
inhibitor
group
phenyl
propyl
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006542704A
Other languages
English (en)
Japanese (ja)
Other versions
JP5107579B2 (ja
JP2007519619A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/040211 external-priority patent/WO2005055928A2/en
Publication of JP2007519619A publication Critical patent/JP2007519619A/ja
Publication of JP2007519619A5 publication Critical patent/JP2007519619A5/ja
Application granted granted Critical
Publication of JP5107579B2 publication Critical patent/JP5107579B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006542704A 2003-12-02 2004-12-01 新規の種類のヒストン脱アセチル化酵素阻害剤としてのＺｎ２＋キレートモチーフ係留短鎖脂肪酸 Expired - Fee Related JP5107579B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52634803P 2003-12-02 2003-12-02
US60/526,348 2003-12-02
PCT/US2004/040211 WO2005055928A2 (en) 2003-12-02 2004-12-01 Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011144993A Division JP5702681B2 (ja) 2003-12-02 2011-06-29 新規の種類のヒストン脱アセチル化酵素阻害剤としてのＺｎ２＋キレートモチーフ係留短鎖脂肪酸

Publications (3)

Publication Number Publication Date
JP2007519619A JP2007519619A (ja) 2007-07-19
JP2007519619A5 true JP2007519619A5 (https=) 2011-08-18
JP5107579B2 JP5107579B2 (ja) 2012-12-26

Family

ID=34676611

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006542704A Expired - Fee Related JP5107579B2 (ja) 2003-12-02 2004-12-01 新規の種類のヒストン脱アセチル化酵素阻害剤としてのＺｎ２＋キレートモチーフ係留短鎖脂肪酸
JP2011144993A Expired - Fee Related JP5702681B2 (ja) 2003-12-02 2011-06-29 新規の種類のヒストン脱アセチル化酵素阻害剤としてのＺｎ２＋キレートモチーフ係留短鎖脂肪酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011144993A Expired - Fee Related JP5702681B2 (ja) 2003-12-02 2011-06-29 新規の種類のヒストン脱アセチル化酵素阻害剤としてのＺｎ２＋キレートモチーフ係留短鎖脂肪酸

Country Status (9)

Country Link
US (2) US9115090B2 (https=)
EP (1) EP1696898B1 (https=)
JP (2) JP5107579B2 (https=)
AU (1) AU2004296764B2 (https=)
CA (1) CA2552279C (https=)
DK (1) DK1696898T3 (https=)
ES (1) ES2562778T3 (https=)
HU (1) HUE028490T2 (https=)
WO (1) WO2005055928A2 (https=)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
CA2518318A1 (en) 2003-03-17 2004-09-30 Takeda San Diego, Inc. Histone deacetylase inhibitors
DK1696898T3 (en) 2003-12-02 2016-02-22 Univ Ohio State Res Found ZN2 + -CHELATING DESIGN-BASED SHORT-CHAIN FAT ACIDS AS AN UNKNOWN CLASS OF HISTONDEACETYLASE INHIBITORS
JP2008505969A (ja) * 2004-07-12 2008-02-28 メルク　エンド　カムパニー　インコーポレーテッド ヒストン脱アセチル化酵素の阻害剤
JP2008524246A (ja) 2004-12-16 2008-07-10 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
US7642253B2 (en) 2005-05-11 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
EA200800321A1 (ru) 2005-07-14 2008-06-30 Такеда Сан Диего, Инк. Ингибиторы гистондеацетилазы
CA2633010A1 (en) * 2005-12-19 2007-06-28 Methylgene Inc. Histone deacetylase inhibitors for enhancing activity of antifungal agents
US8796330B2 (en) 2006-12-19 2014-08-05 Methylgene Inc. Inhibitors of histone deacetylase and prodrugs thereof
EP1973872A4 (en) * 2006-12-19 2012-05-09 Methylgene Inc HISTONDEACETYLASE HEMMER AND PROPHARMAKA THEREOF
CN101417967A (zh) * 2007-10-26 2009-04-29 浙江海正药业股份有限公司 组蛋白去乙酰酶抑制剂、其组合物及其应用
EP2330894B8 (en) 2008-09-03 2017-04-19 BioMarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
BRPI0922770A2 (pt) * 2008-12-01 2019-09-24 Procter & Gamble sistemas de perfume
GB0903480D0 (en) * 2009-02-27 2009-04-08 Chroma Therapeutics Ltd Enzyme Inhibitors
KR20120031170A (ko) * 2009-06-08 2012-03-30 길리애드 사이언시즈, 인코포레이티드 알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
WO2011103563A1 (en) * 2010-02-22 2011-08-25 Arno Therapeutics, Inc Methods and compositions for inhibiting and preventing the growth of malignant mast cells
US8546588B2 (en) * 2010-02-26 2013-10-01 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
WO2011106632A1 (en) * 2010-02-26 2011-09-01 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
US20140107166A1 (en) * 2011-02-14 2014-04-17 Dana-Farber Cancer Institute, Inc. Histone deacetylase inhibitors and methods of use thereof
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US9540395B2 (en) 2011-02-28 2017-01-10 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2013041407A1 (en) * 2011-09-19 2013-03-28 Cellzome Ag Hydroxamic acids as hdac6 inhibitors
WO2013052110A1 (en) * 2011-10-03 2013-04-11 The Trustees Of Columbia University In The City Of New York Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
WO2014164784A1 (en) * 2013-03-12 2014-10-09 Arno Therapeutics Hdac inhibitor polymorphic forms and methods of use
WO2014143666A1 (en) 2013-03-15 2014-09-18 Biomarin Pharmaceutical Inc. Hdac inhibitors
JP6473152B2 (ja) 2013-11-20 2019-02-20 オハイオ・ステイト・イノベーション・ファウンデーション がん関連悪液質を抑制するためのｈｄａｃ阻害剤
WO2015100363A1 (en) 2013-12-23 2015-07-02 The Trustees Of Columbia University In The City Of New York Selective hdac6 inhibitors
US10442788B2 (en) 2015-04-01 2019-10-15 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US10738035B2 (en) 2015-05-13 2020-08-11 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
EP3307746A1 (en) * 2015-05-18 2018-04-18 National and Kapodistrian Universty of Athens Autotaxin inhibitors and uses thereof
US10179131B2 (en) 2015-07-13 2019-01-15 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US10301255B2 (en) 2015-07-22 2019-05-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2017015451A1 (en) * 2015-07-22 2017-01-26 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10022342B2 (en) 2015-09-02 2018-07-17 Ohio State Innovation Foundation Methods and compositions for treating multiple myeloma
WO2017136403A1 (en) 2016-02-02 2017-08-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
JP6904970B2 (ja) 2016-03-07 2021-07-21 エナンタ ファーマシューティカルズ インコーポレイテッド Ｂ型肝炎抗ウイルス剤
CN109843296A (zh) 2016-06-10 2019-06-04 英安塔制药有限公司 乙型肝炎抗病毒药剂
WO2018223122A1 (en) * 2017-06-02 2018-12-06 Ohio State Innovation Foundation Hdac3-selective inhibitors
US10952978B2 (en) 2017-08-28 2021-03-23 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
TW201927789A (zh) 2017-12-06 2019-07-16 美商因那塔製藥公司 B型肝炎抗病毒試劑
TW201936192A (zh) 2017-12-06 2019-09-16 美商因那塔製藥公司 B 型肝炎抗病毒試劑
WO2019130346A1 (en) * 2017-12-27 2019-07-04 K Syed Zameer Ahmed Novel phenolic compounds from nerium indicum with anti-breast cancer activity
US11058678B2 (en) 2018-01-22 2021-07-13 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2019191166A1 (en) 2018-03-29 2019-10-03 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
UY38383A (es) 2018-09-21 2020-04-30 Enanta Pharm Inc Heterociclos funcionalizados como agentes antivirales
US11198693B2 (en) 2018-11-21 2021-12-14 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
WO2020247561A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
WO2020247575A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11738019B2 (en) 2019-07-11 2023-08-29 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US11236108B2 (en) 2019-09-17 2022-02-01 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents
JP7748392B2 (ja) * 2020-04-30 2025-10-02 グレート ノベル セラピューティクス バイオテック アンド メディカルズ コーポレイション 腫瘍微小環境における免疫調節のためのヒストンデアセチラーゼ阻害剤
CN112516142B (zh) * 2020-12-11 2021-10-15 北京华氏精恒医药科技有限公司 一种具有hdac抑制活性的药物组合物、制备方法及其用途
CN112225737B (zh) * 2020-12-11 2021-04-09 北京鑫开元医药科技有限公司 具有hdac抑制活性的化合物、制备方法、组合物及用途
CN114539098B (zh) * 2022-02-26 2024-05-24 青岛大学 一种双功能hdac6抑制剂、合成方法及应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5668650A (en) * 1979-11-07 1981-06-09 Otsuka Pharmaceut Co Ltd Benzoic acid amide derivative
DE3607993A1 (de) 1986-03-11 1987-09-17 Basf Ag Verfahren zur herstellung von diaziridinen und produkte daraus
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5369108A (en) 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
EP0641204B1 (en) * 1992-05-20 2000-08-16 Merck & Co. Inc. 17-ethers and thioethers of 4-aza-steroids
CA2135173A1 (en) * 1992-05-20 1993-11-25 Bruce E. Witzel Ester derivatives of 4-aza-steroids
US5783593A (en) * 1993-11-04 1998-07-21 Abbott Laboratories Inhibitors of squalene synthetase and protein farnesyltransferase
US5958957A (en) * 1996-04-19 1999-09-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
JP3354090B2 (ja) * 1996-09-30 2002-12-09 シエーリング アクチエンゲゼルシャフト 分化誘導剤
US5776888A (en) * 1997-02-07 1998-07-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
US6034584A (en) * 1997-08-06 2000-03-07 Allen-Bradley Company, Llc Arrangement for mechanically coupling an overload relay to a contactor
JP4405602B2 (ja) 1998-04-16 2010-01-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ヒストン脱アセチル化酵素阻害剤
AU4692399A (en) * 1998-06-17 2000-01-05 Du Pont Pharmaceuticals Company Cyclic hydroxamic acids as metalloproteinase inhibitors
US6320078B1 (en) 1998-07-24 2001-11-20 Mitsui Chemicals, Inc. Method of producing benzamide derivatives
US7658938B2 (en) * 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
JP2001081031A (ja) 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
WO2001034131A2 (en) * 1999-11-10 2001-05-17 Warner-Lambert Company Combination chemotherapy
KR20020070285A (ko) 1999-11-23 2002-09-05 메틸진, 인크. 히스톤 디아세틸라제의 억제제
JP2003528072A (ja) * 2000-03-17 2003-09-24 ブリストル−マイヤーズ スクイブ ファーマ カンパニー マトリックスメタロプロテアーゼおよびＴＮＦ−αの阻害剤としての環状β−アミノ酸誘導体
AU2001248701A1 (en) 2000-03-24 2001-10-03 Methylgene, Inc. Inhibitors of histone deacetylase
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
EP1335898B1 (en) * 2000-09-29 2005-11-23 TopoTarget UK Limited Carbamic acid compounds comprising an amide linkage as hdac inhibitors
US20020172967A1 (en) * 2001-02-13 2002-11-21 Gadek Thomas R. Identification of non-covalent complexes by mass spectrometry
JPWO2002074298A1 (ja) 2001-03-21 2004-07-08 小野薬品工業株式会社 Ｉｌ−６産生阻害剤
ITMI20011733A1 (it) * 2001-08-07 2003-02-07 Italfarmaco Spa Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc
JP3681673B2 (ja) 2001-10-31 2005-08-10 Ｊｆｅ炉材株式会社 高炉樋用不定形耐火物
JP2003137866A (ja) * 2001-11-01 2003-05-14 Sankyo Co Ltd フェニレンジアミン誘導体
JPWO2003070691A1 (ja) 2002-02-21 2005-06-09 財団法人大阪産業振興機構 Ｎ−ヒドロキシカルボキサミド誘導体
EP1490015B1 (en) * 2002-03-15 2009-09-23 Wayne State University Novel 2-amino-9-((2-hydroxymethyl) cyclopropylidenemethyl) purines as antiviral agents
US20030225054A1 (en) * 2002-06-03 2003-12-04 Jingwu Duan Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents
TW200426138A (en) * 2002-12-10 2004-12-01 Hoffmann La Roche Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives, their manufacture and use as pharmaceutical agents
ITMI20030025A1 (it) * 2003-01-10 2004-07-11 Italfarmaco Spa Derivati dell'acido idrossammico ad attivita' antinfiammatoria.
WO2004096140A2 (en) * 2003-04-25 2004-11-11 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
JP4939941B2 (ja) * 2003-08-26 2012-05-30 株式會社アモーレパシフィック ヒドロキサム酸誘導体及びその製造方法
WO2005019162A1 (en) * 2003-08-26 2005-03-03 Amorepacific Corporation Hydroxamic acid derivatives and the method for preparing thereof
DK1696898T3 (en) 2003-12-02 2016-02-22 Univ Ohio State Res Found ZN2 + -CHELATING DESIGN-BASED SHORT-CHAIN FAT ACIDS AS AN UNKNOWN CLASS OF HISTONDEACETYLASE INHIBITORS
SG155222A1 (en) * 2004-08-13 2009-09-30 Genentech Inc Thiazole based inhibitors of atp-utilizing enzymes

Similar Documents

Publication Publication Date Title
JP2007519619A5 (https=)
RU2420522C2 (ru) Новый класс ингибиторов гистондеацетилаз
KR920021578A (ko) 포스프노/비아릴 치환된 디펩티드 유도체
US6927228B2 (en) Biaromatic compound activators of PPARγ-type receptors
RU2437877C2 (ru) Новые производные тиофена в качестве агонистов рецептора s1p1/edg1
CA2458035A1 (en) Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
FR2861076B1 (fr) Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
RU2011110435A (ru) Пролекарства метилгидрофумарата, фармацетические композиции с ними и способы применения
JP2019503386A5 (https=)
RU2008106058A (ru) Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона
CA2446326A1 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
CA2396158A1 (en) Dipeptide nitrile cathepsin k inhibitors
RU99105567A (ru) Производные пропионовой кислоты и их использование
RU2012129737A (ru) Замещенные бензамидные производные
US20070105913A1 (en) Alkynyl aryl carboxamides
RU2383542C2 (ru) Замещенные гидантоины
JP2004533450A5 (https=)
BRPI0711208A2 (pt) compostos, intermediários para a sìtemse dos compostos, processo, composição farmacêutica, uso de um composto e usos
JP2005533013A5 (https=)
RU2009148507A (ru) Производное тетрагидроизохинолин-1-она или его соль
US4310517A (en) Tumor-resolving and histolytic medicaments and their use
JP2005522492A5 (https=)
JP2003506438A (ja) 抗菌剤
US20090124620A1 (en) Plasminogen activator inhibitor-1 inhibitor